Compare ANL & RPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANL | RPD |
|---|---|---|
| Founded | 2004 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Computer Software: Prepackaged Software |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 703.3M | 780.5M |
| IPO Year | 2022 | 2015 |
| Metric | ANL | RPD |
|---|---|---|
| Price | $14.86 | $6.83 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 23 |
| Target Price | ★ $20.00 | $15.05 |
| AVG Volume (30 Days) | 677.7K | ★ 2.0M |
| Earning Date | 04-10-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.36 |
| Revenue | N/A | ★ $685,083,000.00 |
| Revenue This Year | $36.02 | N/A |
| Revenue Next Year | N/A | $0.54 |
| P/E Ratio | ★ N/A | $18.07 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.88 | $4.97 |
| 52 Week High | $17.25 | $27.10 |
| Indicator | ANL | RPD |
|---|---|---|
| Relative Strength Index (RSI) | 58.79 | 62.68 |
| Support Level | $1.36 | $5.10 |
| Resistance Level | $17.25 | $7.17 |
| Average True Range (ATR) | 1.97 | 0.38 |
| MACD | -0.18 | 0.15 |
| Stochastic Oscillator | 59.34 | 92.25 |
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.